
Anwuligan
CAS No. 107534-93-0
Anwuligan( Macelignan )
Catalog No. M17798 CAS No. 107534-93-0
Anwuligan is a lignan isolated from nutmeg with antimicrobial and anticariogenic activity against Streptococcus mutans and other streptococcus species.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 82 | In Stock |
![]() ![]() |
5MG | 149 | In Stock |
![]() ![]() |
10MG | 249 | In Stock |
![]() ![]() |
25MG | 449 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameAnwuligan
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnwuligan is a lignan isolated from nutmeg with antimicrobial and anticariogenic activity against Streptococcus mutans and other streptococcus species.
-
DescriptionMacelignan is a lignan which can be found in the nutmeg. Macelignan acts as an NSAID with antioxidant, free radical scavenging, and neuroprotective activities.
-
In VitroMacelignan (1-50 μM; 72 hours) does not reduce cell viability alone, however, UVB treatment, even at the lowest dose of 30 mJ/cm2, reduces HaCaT cell viability in a dose-dependent mannner,it reduces approximately 80% of control values at 100 μM in hacat cells.Macelignan (0.1-1 μM; 24 hours) decreases COX-2 expression in a concentration-dependent manner,and at the highest concentration of macelignan (1 μM) , COX-2 expression is inhibited by almost 50% in hacat cells. TCell Viability Assay Cell Line:Hacat cells Concentration:1 μM; 2.5 μM; 5 μM; 10 μM; 15 μM; 50 μM Incubation Time:72 hours Result:Induced cell death by UVB irradiation at 30 mJ/cm2 from 10 μM.Western Blot Analysis Cell Line:Hacat cellsConcentration:0.1 μM; 0.5 μM;1 μM Incubation Time:24 hours Result:Reduced UVB-induced COX-2 expression in cells.
-
In VivoMacelignan (oral administration; 15 mg/kg; every day for three weeks) exhibits?in vivo anti-diabetic effects. The baseline (day 0) fasting blood glucose levels does not differ between groups; at the end of the experiment, the values of the Macelignan-treated group are significantly lower compared to the diabetic control group in C57BL/KsJ-db/db?mice. Animal Model:Male C57BL/KsJ-db/db?mice Dosage:15 mg/kg Administration:Oral administration; 15 mg/kg; every day for three weeksResult:Significantly reduced the blood glucose levels in mice.
-
SynonymsMacelignan
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorOthers
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number107534-93-0
-
Formula Weight328.41
-
Molecular FormulaC20H24O4
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 30 mg/mL; 91.35 mM
-
SMILESc1(c(cc(cc1)C[C@@H]([C@@H](Cc1cc2OCOc2cc1)C)C)OC)O
-
Chemical NamePhenol, 4-((2S,3R)-4-(1,3-benzodioxol-5-yl)-2,3-dimethylbutyl)-2-methoxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yang X,et al. [Selection of mobile phases for the determination of gamma-schisandrin and multi-active constituents in Schisandra chinensis and its preparations by high performance liquid chromatography].
molnova catalog



related products
-
Giredestrant
Giredestrant potently competes with estradiol for binding and induces a conformational change within the ER ligand binding domain.?Giredestrant has anti-tumor activity.
-
GDC-0810
GDC-0810 (ARN-810, Brilanestrant) is a non-steroidal, orally bioavailable selective estrogen receptor degrader (SERD) with IC50 of 0.7 nM (ER-α degradation).
-
Methyl Isoferulate
This product is isolated and purified from the leaves of Phyllostachys heterocycla.